Oddo BHF - Vivendi SE (VIV) Vivendi : Qui est Havas (avant sa cotation) ?

Report

Oddo BHF

Jerôme Bodin

Vivendi : Qui est Havas (avant sa cotation) ?

>Vers une nouvelle cotation d’Havas, 8 ans après son rachat par Vivendi - Nous avons publié une note sur Groupe Canal+ le 23/09. Dans la perspective de la scission de Vivendi, qui devrait intervenir d’ici fin 2024, nous proposons une seconde analyse et vue d’ensemble d’Havas sur la base des données actuellement disponibles et publiques. Havas devrait être le troisième actif coté, en termes de taille, issu de Vivendi après Canal+ et Lagardère/Louis Hachette. Le group...

07/10/2024 1 FR

Underlying

Vivendi SE

Vivendi is an audiovisual group active in the entertainment industry with activities in music, TV, cinema, mobile, fixed and internet, and games. Co.'s operations are divided into five businesses: Canal+ Group which produces and distributes pay-TV in France, analog or digital, and is involved in film making; Universal Music Group which sells recorded music (physical and digital media); GVT which serves as a telecommunication operator for fixed ultra high-speed broadband, fixed-line telecommunications and Pay-TV in Brazil; SFR which is engaged in mobile phone services in France, as well as fixed and ADSL services; and Other Activities which involves ticketing, Wengo and Watchever.

See profile

FR0000127771 Euronext Paris France

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Jerôme Bodin

Other Reports on these Companies

BusinessWire

Vivendi : assignation en référé de CIAM, actionnaire à 0,025 %, en vue d’ajourner l’assemblée générale du 9 décembre 2024

PARIS--(BUSINESS WIRE)-- Regulatory News: Vivendi (Paris:VIV) prend acte de l’assignation en référé qui lui a été délivrée ce jour par CIAM devant le Président du Tribunal de commerce de Paris, en vue d’une audience le 4 décembre prochain. CIAM demande que l’assemblée générale mixte de Vivendi du 9 décembre soit ajournée jusqu’à ce qu’il soit statué sur deux autres actions de CIAM : une action au fond, engagée à bref délai devant le Tribunal de commerce de Paris, contestant la validité du projet de scission ; un recours devant la Cour d’appel de Paris contre la décision de l’AMF du 1...

2h / 21m 2h / 21m 1 FR

SmartInsider

Vivendi: 1 director

A director at Vivendi bought 4,000 shares at 8.835EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board member...

Free Trial

9h / 47m 9h / 47m 1 EN

BusinessWire

Vivendi : point d’étape sur le projet de scission et tenue des Capital Markets Day de Canal+ et de Havas

PARIS--(BUSINESS WIRE)-- Regulatory News: Vivendi (Paris:VIV) a appelé ses actionnaires à se prononcer sur la séparation de Canal+, de Havas et de Louis Hachette Group (qui regroupera sa participation de 66,53 % dans Lagardère et 100 % de Prisma Media) lors d’une Assemblée générale mixte des actionnaires qui se tiendra le 9 décembre prochain. Canal+ organise un Capital Markets Day le 18 novembre au cours duquel seront présentées la stratégie et les ambitions de cette société dans la perspective de l’admission aux négociations de ses actions ordinaires au London Stock Exchange prévue le 16...

November 18, 2024 November 18, 2024 1 FR

Grünenthal : Grünenthal prices 2031 SSNs at 4.625%

Grünenthal priced the new 2031 SSNs at 4.625%. The instrument matures on 15 November 2031.

3h / 5m 3h / 5m 1 EN

Markus Schmitt

Markus Schmitt

Grünenthal : Grünenthal prices 2031 SSNs at 4.625%

Grünenthal priced the new 2031 SSNs at 4.625%. The instrument matures on 15 November 2031.

3h / 11m 3h / 11m 1 FR

Anne-Barbara Nicco

Anne-Barbara Nicco

Flos B&B Italia (ex-IDG) : Credit update on the eve of the refinancing of the FRN 2026.

Given the excellent performance of the 2028 bond since its issuance with a 10% coupon a year earlier (spread tightening twice that of the JPM 'B' index), we avail ourselves of the Q3 earnings release to review trends in the issuer's fundamentals and the yields offered by its bond due 2028 on the eve of the refinancing of the FRN due 2026.

3h / 17m 3h / 17m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Vivendi : Qui est Havas (avant sa cotation) ?

Vivendi : assignation en référé de CIAM, actionnaire à 0,025 %, en vue d’ajourner l’assemblée générale du 9 décembre 2024

Vivendi: 1 director

Vivendi : point d’étape sur le projet de scission et tenue des Capital Markets Day de Canal+ et de Havas

Grünenthal : Grünenthal prices 2031 SSNs at 4.625%

Grünenthal : Grünenthal prices 2031 SSNs at 4.625%

Flos B&B Italia (ex-IDG) : Credit update on the eve of the refinancing of the FRN 2026.

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe